Soderquist Ola 4/A
4/A · BIOXYTRAN, INC · Filed Nov 18, 2025
Insider Transaction Report
Form 4/AAmended
BIOXYTRAN, INCBIXT
Soderquist Ola
CFO10% Owner
Transactions
- Other
preferred
2024-10-25$0.55/sh+10,069,396$5,487,821→ 13,976,456 total - Other
common
2024-10-25$0.00/sh+500,000$500→ 500,000 total - Other
preferred
2024-10-25$0.01/sh+100,000$500→ 13,876,456 total
Footnotes (2)
- [F1]The Shares were issued as payment for the sale of NDPD Pharma to Bioxytran
- [F2]A 1:5 exchange of Preferred Stock (earlier issued under section 16b-3) into shares of Common Stock.